Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial

BACKGROUND: A standard low-dosing schedule of rituximab (RTX; 2 × 500 mg or 1 × 1000 mg) is as effective for active rheumatoid arthritis (RA) as the registered dose (2 × 1000 mg). Moreover, several small uncontrolled studies suggest that even lower-dosed treatment with RTX also leads to good treatme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: den Broeder, Alfons A., Verhoef, Lise M., Fransen, Jaap, Thurlings, Rogier, van den Bemt, Bart J. F., Teerenstra, Steven, Boers, Nadine, den Broeder, Nathan, van den Hoogen, Frank H. J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5577818/
https://ncbi.nlm.nih.gov/pubmed/28854956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2134-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados